Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Peter van Geel"'
Autor:
Annelieke Zeilemaker, Jasper Koenders, Anita M. Schelen, H. Berna Beverloo, Anikó Szabó, Peter J. M. Valk, Carla Exalto, Anita W. Rijneveld, Jan J. Cornelissen, Peter van Geel, Mathijs A. Sanders, Remco Hoogenboezem
Publikováno v:
Blood. 128:4067-4067
BCR-ABL1 and BCR-ABL1-like acute lymphoblastic leukemia (ALL) are two major pre-B cell acute leukemia subtypes characterized by genetic alterations affecting lymphoid-specific transcription factors. Studies examining the chain of genetic events neces
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1427cf1e45cd9289bd4706d47e07250d
https://doi.org/10.1182/blood.v128.22.4067.4067
https://doi.org/10.1182/blood.v128.22.4067.4067
Autor:
Vladan Vucinic, Jan J. Cornelissen, Larissa De Graaf, Georgine E. de Greef, Dietger Niederwieser, Meriam Grootes, Wendimagegn Ghidey Alemayehu, Eefke Petersen, Eric Braakman, Otto Visser, Carla Engelman, Peter van Geel
Publikováno v:
Blood. 124:2451-2451
Plerixafor (PXF) is a bicyclam molecule, which acts as a reversible inhibitor of SDF-1 binding to CXCR4. A single injection results in immediate release of CD34+ cells into the peripheral blood. Sofar, PXF has been used for stem cell mobilization onl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9596702dad144e33d85a773ab4f84ef
https://doi.org/10.1182/blood.v124.21.2451.2451
https://doi.org/10.1182/blood.v124.21.2451.2451